- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Lumexa Imaging Draws Bullish Analyst Calls On Heels Of IPO | 1 | Benzinga.com | ||
| Mo | Deutsche Bank startet Coverage für Lumexa Imaging mit Kaufempfehlung und 25 % Kurspotenzial | 1 | Investing.com Deutsch | ||
| Mo | Deutsche Bank initiates coverage on Lumexa Imaging stock with Buy rating | 3 | Investing.com | ||
| Mo | Raymond James initiates Lumexa Imaging stock with Outperform rating | 2 | Investing.com | ||
| Mo | Wells Fargo initiates Lumexa Imaging stock with Overweight rating | 2 | Investing.com | ||
| Mo | Lumexa Imaging stock initiated with Outperform rating by William Blair | 2 | Investing.com | ||
| Mo | William Blair startet Coverage für Lumexa Imaging mit "Outperform" | - | Investing.com Deutsch | ||
| Mo | Jefferies stuft Lumexa Imaging mit "Buy" ein und sieht 31 % Kurspotenzial | 1 | Investing.com Deutsch | ||
| LUMEXA IMAGING Aktie jetzt für 0€ handeln | |||||
| Mo | JPMorgan initiates Lumexa Imaging stock with Overweight rating, $23 target | 1 | Investing.com | ||
| Mo | Jefferies initiates coverage on Lumexa Imaging stock with Buy rating | 1 | Investing.com | ||
| 15.12.25 | S&P stuft Lumexa Imaging nach Börsengang und reduziertem PE-Einfluss auf 'B+' hoch | 12 | Investing.com Deutsch | ||
| 12.12.25 | Lumexa Imaging Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 12.12.25 | Welsh Carson scores IPO exit as Lumexa Imaging raises $463m in US debut | 4 | Private Equity Insights | ||
| 12.12.25 | Lumexa Imaging raises $463m in IPO | 9 | Private Equity Wire | ||
| 12.12.25 | Lumexa Imaging Holdings, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 11.12.25 | Moody's stuft Lumexa Imaging nach erfolgreichem Börsengang auf B2 hoch | 4 | Investing.com Deutsch | ||
| 11.12.25 | Lumexa Imaging valued at $1.76 billion as shares edge up in Nasdaq debut | 2 | Reuters | ||
| 11.12.25 | Lumexa Imaging prices IPO at $18.50, within the range | 1 | Renaissance Capital | ||
| 11.12.25 | Lumexa Imaging Holdings, Inc. - 8-A12B, Registration of securities | - | SEC Filings | ||
| 11.12.25 | Welsh Carson-backed Lumexa Imaging raises $463 million in US IPO | 2 | Reuters |
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 44,900 | +1,72 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers vor Zahlen zum ersten Geschäftsquartal auf "Buy" mit einem Kursziel von 60 Euro belassen. Der Medizintechnikkonzern... ► Artikel lesen | |
| FRESENIUS | 47,690 | -0,08 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| INTELLIGENT BIO SOLUTIONS | 11,000 | 0,00 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins | NEW YORK, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,500 | +0,82 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,020 | +3,96 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,260 | +2,24 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 33,130 | +7,70 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 40,380 | +1,92 % | Abend-Update: Carl Zeiss Meditec-Aktie im Fokus - wann platzt endlich der Knoten? | ||
| BETA BIONICS | 29,570 | +1,09 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PROGYNY | 26,645 | +3,52 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| CERIBELL | 20,810 | 0,00 % | Protara, CeriBell rise on FDA breakthrough designations | ||
| AVEANNA HEALTHCARE | 8,220 | +1,61 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| PACS GROUP | 39,720 | +0,51 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| ADAPTHEALTH | 9,780 | +1,14 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber | ||
| OTTOBOCK | 67,75 | +3,91 % | IPO-Rückblick 2025: TKMS, Klarna, Ottobock und Circle im Anleger-Check | Guten Tag, liebe Leserinnen und Leser,
2025 war ein vergleichsweise starkes Jahr für Neuemissionen. Allein in der ersten Jahreshälfte wagten weltweit 539 Unternehmen den Schritt an die Börse und sammelten... ► Artikel lesen |
LUMEXA IMAGING HOLDINGS INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 16,840 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LUMEXA IMAGING HOLDINGS INC finden Sie auf Wallstreet Online.